Two Indians Indicted in U.S. Counterfeit Ozempic Smuggling Scheme
By United One News · AI-generated summary of 2 outlets' reporting
Published
AI-generated summary of the coverage listed below:
Two Indian nationals were indicted by the U.S. Justice Department for allegedly smuggling counterfeit Ozempic from China to U.S. distributors between July 2023 and April 2024.
- Swapnadip Roy and Vicky Ramancha are the accused individuals.
- They allegedly obtained counterfeit Ozempic in China.
- The drugs were sold to U.S. distributors at discounted prices.
Covered by 2 outlets across the spectrum: 50% left, 50% center, 0% right.
How each side framed it
Left-leaning: Focus on the indictment and the alleged smuggling route from China to U.S. distributors. (AI-generated summary of how this side framed it)
U.S. says two Indian nationals indicted in counterfeit Ozempic smuggling scheme
Center: Highlights the indictment and the involvement of Indian nationals in the counterfeit drug case. (AI-generated summary of how this side framed it)
Counterfeit Ozempic case: 2 Indians indicted in US
Timeline
First reported by Economic Times on ; 2 articles from 2 outlets so far.
Who is covering this story
- Left-leaning (1): The Hindu
- Center (1): Economic Times